Most product development programmes follow the same unwritten sequence. Engineering designs the product. Procurement sources the components. Then, somewhere near the end, someone calls the manufacturing partner.
It's a logical order, on the surface. In practice, it's one of the most reliable ways to guarantee avoidable problems.
For many Original Electronics Manufacturers (OEMs), the manufacturing partner enters the picture only after key decisions have already been made: the architecture is fixed, the BOM is largely locked, and the design is heading towards tooling. By that point, any issues the manufacturing partner identifies aren't design inputs. They're obstacles.
The result is predictable: rework, redesign, delays, and costs that nobody budgeted for. And much of it could have been avoided if the Electronics Manufacturing Services (EMS) partner had been in the room sooner.
The point where problems become expensive
There's a principle that most experienced engineers know, but not every company puts into practice: the cost of fixing a design defect rises significantly with each stage of development it passes through. Catch a component incompatibility at the design stage, and it's a conversation. Catch it after tooling is complete, and it's a project crisis.
This is especially true when the leap from development to volume production isn't well managed. Prototype builds can tolerate workarounds. Production lines can't. What feels like a minor assembly quirk at low volumes becomes a yield problem at scale. What looks like a reasonable material choice on a drawing becomes a procurement headache in a constrained supply chain.
The earlier an EMS provider is involved, the more of these issues can be addressed when they're still inexpensive to fix.
When is early, exactly?
It's worth being specific, because "early" means different things to different companies.
The ideal point of engagement is at the concept or early design stage, before architecture decisions are finalised and before the BOM takes shape. At this point, an EMS partner can meaningfully influence the choices that will define producibility, cost, and quality. That's when the conversation is most valuable.
Engaging at the prototype stage is better than nothing, and still leaves room to address many issues before they become embedded. But by that point, some decisions are already harder to unpick. Bringing the EMS partner in only at New Product Introduction (NPI) - which is more common than it should be - means the design is largely fixed, and the focus shifts from prevention to damage limitation.
The question isn't whether to involve manufacturing early. It's how early, and what that involvement should look like at each stage.
What early involvement actually looks like
Early engagement isn't simply about reviewing a design before it goes to production. Done well, it spans several distinct disciplines that each reduce risk in a different way.
Design for Manufacture (DfM)
Design for Manufacture (DfM) is a prime example. It's the process of reviewing a design to ensure it can be built reliably and efficiently: examining component tolerances, identifying assembly constraints, evaluating testability, and flagging anything that might cause variation or failure at volume. The goal is to surface and resolve these issues while they're still a design problem, not a production one.
Design for Test (DfT)
Design for Test (DfT) also deserves its own attention. Test coverage is often treated as something to figure out once the design is done. But a product that hasn't been designed with testability in mind can be extremely difficult and costly to test at volume.
Access points, boundary scan architecture, in-circuit test feasibility: these are decisions that need to be made during design, not after it. In regulated sectors like medical and transportation, where traceability and test coverage are non-negotiable, getting this wrong isn't just an efficiency problem. It's a compliance risk.
Design for Excellence (DfX)
Design for Excellence (DfX) extends this thinking further. It asks not just whether something can be manufactured, but whether it can be manufactured well, at volume, over time, and with the right materials. Reliability, serviceability, sustainability, and supply chain resilience are all design decisions, and they're best made with manufacturing input at the table.
This is where an EMS partner's cross-sector experience genuinely adds value. Having worked across medical, transportation, and industrial programmes, ESCATEC brings a perspective on component longevity and supply risk that sits outside most OEM engineering functions.
Sourcing strategy & production readiness
Sourcing strategy is another area that benefits enormously from early collaboration. Component selection made in isolation, without visibility of supply chain realities, creates risk that only becomes apparent later. Lead times fluctuate, components are discontinued, and single-source dependencies leave programmes exposed.
An EMS partner with established procurement relationships and strategic sourcing capability can flag these issues before the BOM is locked. That's a very different conversation from the one that happens when substitutions are needed mid-production.
Getting a product from prototype to volume production reliably is harder than it looks. It requires bespoke tooling, process development, quality system integration, and careful validation at each stage. None of that can be rushed, and none of it should be a surprise. Plan for it early, and it's a managed process. Leave it to the end, and it becomes a bottleneck.
The cost of the alternative
When manufacturing input comes late, the consequences tend to follow a recognisable pattern. Designs are redesigned. Components already specified have to be substituted. Tooling that was built to a flawed assembly process has to be remade. Schedules slip while the production team catches up with decisions that were made without them. And throughout, there's a compounding cost: financial, reputational, and competitive, of a product that isn't in market.
Why it doesn't always happen
If early involvement is so clearly beneficial, why isn't it standard practice?
The honest answer is that there are real barriers, and most of them are organisational rather than technical.
Internal development processes often have formal gates that determine when external partners are brought in, and manufacturing typically sits behind procurement, which sits behind engineering sign-off. Changing that sequence requires intent and, sometimes, a degree of internal resistance to overcome.
IP concerns are another common reason for hesitation. Sharing early-stage designs with an external manufacturer feels risky, particularly for OEMs developing novel or proprietary technology. A well-chosen EMS partner will have robust confidentiality agreements and the discretion to match, but that trust takes time to establish and needs to be addressed directly.
There's also a subtler issue: early engagement requires the OEM to be genuinely open to input. That means being willing to revisit decisions, consider alternatives, and treat the EMS partner as a technical collaborator rather than a supplier who executes instructions. Not every organisation is structured or culturally ready for that. But the ones that are consistently get better outcomes.
A conversation that changes the outcome
The case for early manufacturing involvement is evidenced in every programme where things went well and every one where they didn't. The OEMs who partner with their EMS provider at the design stage, rather than handing over a finished drawing, consistently see shorter time-to-market, fewer surprises in production, and stronger unit economics.
For procurement and operations professionals, early engagement also simplifies supplier management. When the EMS partner understands the product from its inception, communication is faster, issues are resolved more quickly, and the relationship operates more like a collaboration than a transaction.
ESCATEC's global footprint, spanning the UK, Malaysia, Switzerland, the Czech Republic, and Bulgaria, means that engineering teams can work closely with production sites wherever they're based. That proximity supports the kind of iterative, joined-up collaboration that early engagement requires: design and engineering work happening in close coordination with the teams who will ultimately build the product at volume.
That kind of partnership doesn't happen when manufacturing is brought in at the end. It happens when the conversation starts early, and both parties treat the programme as a shared problem to solve.
If your next product development programme is approaching, the most valuable conversation you can have isn't about production capacity. It's about how soon your EMS partner can be in the room.
Ready to discuss your product? Get in touch with the ESCATEC team.
FAQs
1. When in the product development process should we involve an EMS partner?
You should involve an EMS partner as early as the concept or early design stage, before architecture decisions are locked and before the BOM takes shape. At this point, the EMS partner can meaningfully influence the choices that define producibility, cost, and quality. Engaging at prototype stage is still valuable, but some decisions will already be harder to change. Waiting until New Product Introduction (NPI) means the design is largely fixed, and the focus shifts from preventing problems to managing them.
2. Will sharing early-stage designs with an EMS partner put our IP at risk?
Sharing early-stage designs with an EMS partner doesn't have to put your IP at risk, provided the right protections are in place. A reputable EMS partner will have robust confidentiality agreements and the processes to back them up. The conversation about IP protection should happen before any designs are shared, not after. If a potential partner isn't willing to address this directly and transparently, that tells you something important about how the broader relationship would be managed.
3. What's the difference between DfM, DfT, and DfX?
DfM, DfT, and DfX each address a different aspect of design readiness for manufacturing. DfM (Design for Manufacturability) focuses on whether a product can be built reliably and efficiently at volume. DfT (Design for Test) ensures the product can be tested effectively, with the right access points, boundary scan architecture, and test coverage built into the design from the outset. DfX (Design for Excellence) takes the broadest view, asking whether the product can be manufactured well over time, with consideration for reliability, serviceability, sustainability, and supply chain resilience. All three are best addressed during design, not after it.
4. What does early EMS involvement mean for our internal development process?
Involving an EMS partner earlier typically requires revisiting when external partners enter your development gate process. In most OEM organisations, manufacturing sits behind procurement, which sits behind engineering sign-off. Shifting that sequence takes intent and may require internal alignment. It doesn't mean handing over control of the design. It means treating your EMS partner as a technical collaborator from an earlier stage, which most OEMs find significantly reduces the rework, delays, and cost they would otherwise encounter further down the line.
